Social Media Content Creators Driving Parallel Market for Unlicensed Slimming Drug
A shadow economy for unlicensed slimming medications is propelled by social media fitness personalities and vendors on messaging platforms, according to new investigations.
Investigational Treatment Gaining Traction Via Social Media
The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged fat-burning effects. Followers are encouraged to contact these accounts privately for source information, while also obtaining promotional offers.
Thriving Commerce on Messaging Platforms
Separately, a robust market exists on messaging services, where groups with thousands of participants share comparison photos, injection guides and claims of rapid UK delivery. Sellers promote the substance there before redirecting customers to WhatsApp for purchases.
Understanding The Experimental Drug
This medication is an investigational injection developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help patients lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.
Medical Experts Voice Concerns
Nevertheless, physicians and chemists have warned that the sale of what is still an unapproved drug in the United Kingdom is a cause for concern and could lead to users injecting products of unknown origin.
Some experts stated the demand for the experimental drug could be linked to the rising cost of licensed slimming products such as Mounjaro.
Legal Status and Implementation
Marketing retatrutide on social media or messaging apps is illegal in the UK, as it is an unapproved medication that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.
Several influencers attempt to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and distribution can still breach medicines, marketing, and customer regulations, potentially leading to fines, legal action or imprisonment.
Service Reaction and Material Removal
Based on TikTok, the platform has removed problematic content and prohibited related hashtags and query recommendations. The company stated it was committed to keeping the platform safe and allocating resources in enhancing compliance measures.
Digital Trading Operations
Investigations also found communities with up to nine thousand members marketing retatrutide using the platform's built-in search feature, which operates like a online catalog. Typing “retatrutide” immediately displays groups with numerous of members, filled with images of weight loss, glowing reviews and detailed instructions for preparing or injecting at residence.
Within minutes of joining one community, a vendor shared WhatsApp details, where the majority of purchases occur. The seller provided an instruction manual and promised shipping within two days. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None inquired about weight, medical conditions or past usage.
Product Details and Costs
Inside these groups, posts show black plastic parcels with postal service labels, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at home with sterile water, or ready-to-use pens usually priced at £160 for 20mg. When asked how much time a pen should last, vendors give contradictory answers varying between a several days to “depends on your body”.
Platform Oversight and Safety Actions
A representative for Telegram said it actively monitored harmful content on its service including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are injecting substances they cannot confirm. Although the research behind this drug is sound, these online products may not include what they advertise,” said Jason Murphy, the head of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to current price rises for authorized slimming medications such as Mounjaro. “With prices rising, individuals are turning to social media. But fake injections are extremely dangerous. You cannot know what’s inside or whether the environment they were made in was sterile,” she explained.
Her team has previously encountered individuals injured by personal administration from unconfirmed suppliers. “We recognize the frustration, but purchasing from Telegram or communication platforms is gambling with your well-being,” stated Wyllie. “These materials could be contaminated or improperly measured.”
Producer Statement
A spokesperson from Eli Lilly said the substance was in third stage research studies and had not been reviewed or approved by any regulatory agency globally. “Consequently at this point no one can sell [it] for personal consumption,” they said, noting that any item “misleadingly claiming itself as a Lilly experimental substance not yet approved … may expose users to potentially significant health risks”.